-
1
-
-
84879074792
-
A review of the current status of siRNA nanomedicines in the treatment of cancer
-
P. Resnier, T. Montier, V. Mathieu, J.P. Benoit, and C. Passirani A review of the current status of siRNA nanomedicines in the treatment of cancer Biomaterials 34 2013 6429 6443
-
(2013)
Biomaterials
, vol.34
, pp. 6429-6443
-
-
Resnier, P.1
Montier, T.2
Mathieu, V.3
Benoit, J.P.4
Passirani, C.5
-
2
-
-
77951260189
-
Development of double-stranded siRNA labeling method using positron emitter and its in vivo trafficking analyzed by positron emission tomography
-
K. Hatanaka, T. Asai, H. Koide, E. Kenjo, T. Tsuzuku, N. Harada, H. Tsukada, and N. Oku Development of double-stranded siRNA labeling method using positron emitter and its in vivo trafficking analyzed by positron emission tomography Bioconjug. Chem. 21 2010 756 763
-
(2010)
Bioconjug. Chem.
, vol.21
, pp. 756-763
-
-
Hatanaka, K.1
Asai, T.2
Koide, H.3
Kenjo, E.4
Tsuzuku, T.5
Harada, N.6
Tsukada, H.7
Oku, N.8
-
3
-
-
84874032148
-
Systemic delivery of small interfering RNA by use of targeted polycation liposomes for cancer therapy
-
E. Kenjo, T. Asai, N. Yonenaga, H. Ando, T. Ishii, K. Hatanaka, K. Shimizu, Y. Urita, T. Dewa, M. Nango, H. Tsukada, and N. Oku Systemic delivery of small interfering RNA by use of targeted polycation liposomes for cancer therapy Biol. Pharm. Bull. 36 2013 287 291
-
(2013)
Biol. Pharm. Bull.
, vol.36
, pp. 287-291
-
-
Kenjo, E.1
Asai, T.2
Yonenaga, N.3
Ando, H.4
Ishii, T.5
Hatanaka, K.6
Shimizu, K.7
Urita, Y.8
Dewa, T.9
Nango, M.10
Tsukada, H.11
Oku, N.12
-
4
-
-
79952803061
-
Dicetyl phosphate-tetraethylenepentamine-based liposomes for systemic siRNA delivery
-
T. Asai, S. Matsushita, E. Kenjo, T. Tsuzuku, N. Yonenaga, H. Koide, K. Hatanaka, T. Dewa, M. Nango, N. Maeda, H. Kikuchi, and N. Oku Dicetyl phosphate-tetraethylenepentamine-based liposomes for systemic siRNA delivery Bioconjug. Chem. 22 2011 429 435
-
(2011)
Bioconjug. Chem.
, vol.22
, pp. 429-435
-
-
Asai, T.1
Matsushita, S.2
Kenjo, E.3
Tsuzuku, T.4
Yonenaga, N.5
Koide, H.6
Hatanaka, K.7
Dewa, T.8
Nango, M.9
Maeda, N.10
Kikuchi, H.11
Oku, N.12
-
5
-
-
84861681753
-
RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment
-
N. Yonenaga, E. Kenjo, T. Asai, A. Tsuruta, K. Shimizu, T. Dewa, M. Nango, and N. Oku RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment J. Controlled Release 160 2012 177 181
-
(2012)
J. Controlled Release
, vol.160
, pp. 177-181
-
-
Yonenaga, N.1
Kenjo, E.2
Asai, T.3
Tsuruta, A.4
Shimizu, K.5
Dewa, T.6
Nango, M.7
Oku, N.8
-
6
-
-
57149086661
-
Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression
-
M. Aleku, P. Schulz, O. Keil, A. Santel, U. Schaeper, B. Dieckhoff, O. Janke, J. Endruschat, B. Durieux, N. Roder, K. Loffler, C. Lange, M. Fechtner, K. Mopert, G. Fisch, S. Dames, W. Arnold, K. Jochims, K. Giese, B. Wiedenmann, A. Scholz, and J. Kaufmann Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression Cancer Res. 68 2008 9788 9798
-
(2008)
Cancer Res.
, vol.68
, pp. 9788-9798
-
-
Aleku, M.1
Schulz, P.2
Keil, O.3
Santel, A.4
Schaeper, U.5
Dieckhoff, B.6
Janke, O.7
Endruschat, J.8
Durieux, B.9
Roder, N.10
Loffler, K.11
Lange, C.12
Fechtner, M.13
Mopert, K.14
Fisch, G.15
Dames, S.16
Arnold, W.17
Jochims, K.18
Giese, K.19
Wiedenmann, B.20
Scholz, A.21
Kaufmann, J.22
more..
-
7
-
-
84655160875
-
Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery
-
T. Tagami, T. Suzuki, M. Matsunaga, K. Nakamura, N. Moriyoshi, T. Ishida, and H. Kiwada Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery Int. J. Pharm. 422 2012 280 289
-
(2012)
Int. J. Pharm.
, vol.422
, pp. 280-289
-
-
Tagami, T.1
Suzuki, T.2
Matsunaga, M.3
Nakamura, K.4
Moriyoshi, N.5
Ishida, T.6
Kiwada, H.7
-
8
-
-
79955084359
-
Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid
-
H. Hatakeyama, H. Akita, E. Ito, Y. Hayashi, M. Oishi, Y. Nagasaki, R. Danev, K. Nagayama, N. Kaji, H. Kikuchi, Y. Baba, and H. Harashima Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid Biomaterials 32 2011 4306 4316
-
(2011)
Biomaterials
, vol.32
, pp. 4306-4316
-
-
Hatakeyama, H.1
Akita, H.2
Ito, E.3
Hayashi, Y.4
Oishi, M.5
Nagasaki, Y.6
Danev, R.7
Nagayama, K.8
Kaji, N.9
Kikuchi, H.10
Baba, Y.11
Harashima, H.12
-
9
-
-
84857795022
-
Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis
-
Y. Yang, J. Li, F. Liu, and L. Huang Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis Mol. Ther. 20 2012 609 615
-
(2012)
Mol. Ther.
, vol.20
, pp. 609-615
-
-
Yang, Y.1
Li, J.2
Liu, F.3
Huang, L.4
-
10
-
-
45149126142
-
Intracellular delivery of nanoparticles via the HIV-1 tat peptide
-
C.C. Berry Intracellular delivery of nanoparticles via the HIV-1 tat peptide Nanomedicine (Lond) 3 2008 357 365
-
(2008)
Nanomedicine (Lond)
, vol.3
, pp. 357-365
-
-
Berry, C.C.1
-
11
-
-
84863954601
-
Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides
-
I. Nakase, H. Akita, K. Kogure, A. Graslund, U. Langel, H. Harashima, and S. Futaki Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides Acc. Chem. Res. 45 2012 1132 1139
-
(2012)
Acc. Chem. Res.
, vol.45
, pp. 1132-1139
-
-
Nakase, I.1
Akita, H.2
Kogure, K.3
Graslund, A.4
Langel, U.5
Harashima, H.6
Futaki, S.7
-
12
-
-
72149099569
-
The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine
-
Y.S. Choi, J.Y. Lee, J.S. Suh, Y.M. Kwon, S.J. Lee, J.K. Chung, D.S. Lee, V.C. Yang, C.P. Chung, and Y.J. Park The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine Biomaterials 31 2010 1429 1443
-
(2010)
Biomaterials
, vol.31
, pp. 1429-1443
-
-
Choi, Y.S.1
Lee, J.Y.2
Suh, J.S.3
Kwon, Y.M.4
Lee, S.J.5
Chung, J.K.6
Lee, D.S.7
Yang, V.C.8
Chung, C.P.9
Park, Y.J.10
-
13
-
-
84863777813
-
Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles
-
T. Kanazawa, K. Sugawara, K. Tanaka, S. Horiuchi, Y. Takashima, and H. Okada Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles Eur. J. Pharm. Biopharm. 81 2012 470 477
-
(2012)
Eur. J. Pharm. Biopharm.
, vol.81
, pp. 470-477
-
-
Kanazawa, T.1
Sugawara, K.2
Tanaka, K.3
Horiuchi, S.4
Takashima, Y.5
Okada, H.6
-
14
-
-
38949151892
-
Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system
-
K. Kogure, H. Akita, Y. Yamada, and H. Harashima Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system Adv. Drug Deliv. Rev. 60 2008 559 571
-
(2008)
Adv. Drug Deliv. Rev.
, vol.60
, pp. 559-571
-
-
Kogure, K.1
Akita, H.2
Yamada, Y.3
Harashima, H.4
-
15
-
-
0033790915
-
Development of a simple cell invasion assay system
-
S. Yamakawa, Y. Furuyama, and N. Oku Development of a simple cell invasion assay system Biol. Pharm. Bull. 23 2000 1264 1266
-
(2000)
Biol. Pharm. Bull.
, vol.23
, pp. 1264-1266
-
-
Yamakawa, S.1
Furuyama, Y.2
Oku, N.3
-
16
-
-
33750417183
-
Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells
-
S.D. Li, and L. Huang Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells Mol. Pharm. 3 2006 579 588
-
(2006)
Mol. Pharm.
, vol.3
, pp. 579-588
-
-
Li, S.D.1
Huang, L.2
|